Kerola, Tuomas

English

UEF Electronic Publications

A 32-year prospective study of change in body weight and incident dementia: the HonoluluAsia Aging Study.

A n d e r s o n C , T e o K , G a o P , A r i m a H , D a n s A , U n g e r T , C o m m e r f o r d P , D y a l

A new natriuretic peptide in porcine brain.

A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats.

Abnormal left ventricular diastolic filling in chronic thromboembolic pulmonary hypertension: true diastolic dysfunction or left ventricular underfilling?

Accelerated weight loss may precede diagnosis in Alzheimer disease.

Adiposity indicators and dementia over 32 years in Sweden.

Agency recommends suspension of Avandia, Avandamet and Avaglim

allele predicts faster cognitive decline in mild Alzheimer disease.

Alzheimer disease in the US population: prevalence estimates using the 2000 census.

An 18-year follow-up of overweight and risk of Alzheimer disease.

Angiotensin-converting enzyme inhibitors and cognitive decline in older adults with hypertension: results from the cardiovascular health study.

Another cholesterol hypothesis: cholesterol as antioxidant.

Antiatherogenic Functionality of High Density Lipoprotein: How Much versus How Good.

Antihypertensive drugs and incidence of dementia: the Rotterdam Study.

Apolipoprotein E epsilon4 allele, elevated midlife total cholesterol level, and high midlife systolic blood pressure are independent risk factors for late-life Alzheimer disease.

Apolipoprotein E: cholesterol transport protein with expanding role in cell biology.

Assessment of left ventricular ejection fraction and volumes by real-time, two-dimensional echocardiography. A comparison of cineangiographic and radionuclide techniques.

Association between body mass index and mortality in an 80-year-old population.

Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease.

Association of diabetes mellitus and dementia: the Rotterdam Study.

Association of duration and severity of diabetes mellitus with mild cognitive impairment.

Association of incident Alzheimer disease and blood pressure measured from 13 years before to 2 years after diagnosis in a large community study.

Association of metabolic syndrome with Alzheimer disease: a population-based study.

Association of plasma leptin levels with incident Alzheimer disease and MRI measures of brain aging.

Atorvastatin improves left ventricular systolic function and serum markers of inflammation in nonischemic heart failure.

Atrial natriuretic peptides predict mortality in the elderly.

Atrial natriuretic polypeptides (ANP): rat atria store high molecular weight precursor but secrete processed peptides of 25-35 amino acids.

B-type natriuretic peptide plasma levels are elevated in subcortical vascular dementia.

Blood pressure and late-life cognitive function change: a biracial longitudinal population study.

Blood pressure and risk of dementia: results from the Rotterdam study and the Gothenburg H-70 Study.

Blood pressure and survival in the oldest old.

Blood pressure lowering in patients without prior cerebrovascular disease for prevention of cognitive impairment and dementia. Cochrane Database Syst Rev.

Blood-based microcirculation markers in Alzheimer's disease-diagnostic value of midregional pro-atrial natriuretic peptide/C-terminal endothelin-1 precursor fragment ratio.

BNP as a biomarker in heart disease.

Body mass index and incidence of dementia: the PAQUID study.

Brain natriuretic peptide predicts mortality in the elderly.

Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic.

C-reactive protein, cardiovascular risk factors, and mortality in a prospective study in the elderly.

Cardiovascular and biochemical risk factors for incident dementia in the Hypertension in the Very Elderly Trial.

Central nervous system: cholesterol turnover, brain development and neurodegeneration.

Cerebral complications of diabetes: clinical findings and pathogenetic mechanisms.

Cerebrovascular risk factors and preclinical memory decline in healthy APOE {varepsilon}4 homozygotes.

Changes in the use of cardiovascular medicines in the elderly aged 75 years or older--a population-based Kuopio 75+ study.

Cholesterol depletion inhibits the generation of beta-amyloid in hippocampal neurons.

Cholesterol homeostasis and function in neurons of the central nervous system.

Cholesterol modulates alpha-secretase cleavage of amyloid precursor protein.

Cigarette smoking is a risk factor for Alzheimer's Disease: an analysis controlling for tobacco industry affiliation.

Clinical impression of brain natriuretic peptide levels in demented patients without cardiovascular disease.

Clinical utility of Doppler echocardiography and tissue Doppler imaging in the estimation of left ventricular filling pressures: A comparative simultaneous Dopplercatheterization study.

Cognitive effects of insulin in the central nervous system.

Cognitive function in elderly non-insulin-dependent diabetic patients before and after inpatient treatment for metabolic control.

Cognitive Impairment and Mortality in Community-Dwelling Elderly.

Cognitive impairment and mortality in older community residents.

Cognitive impairment and mortality in older mexican americans.

Cognitive impairment and mortality in older primary care patients.

Cognitive impairment in the nondemented elderly. Results from the Canadian Study of Health and Aging.

Cognitive impairment risk: white matter hyperintensity progression matters.

Cognitive impairment without dementia in older people: prevalence, vascular risk factors, impact on disability. The Italian Longitudinal Study on Aging.

Congestive heart failure and cognitive impairment in an older population.

Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop.

Coronary heart disease statistics 2010 edition, British Heart Foundation.

Correlation between cognitive impairment and left ventricular diastolic dysfunction in patients with cardiovascular diseases.

Correlation between cognitive impairment and prognostic parameters in patients with congestive heart failure.

Cost-effectiveness of screening with B-type natriuretic peptide to identify patients with reduced left ventricular ejection fraction.

Dementia and disability outcomes in large hypertension trials: lessons learned from the systolic hypertension in the elderly program (SHEP) trial.

Diabetes and other vascular risk factors for dementia: which factor matters most? A systematic review.

Diastolic heart failure can be diagnosed by comprehensive two-dimensional and Doppler echocardiography.

Dose-response and trend analysis in epidemiology: alternatives to categorical analysis.

E v an s D A , F u n k en s te i n H H , A l b e r t

Early impairment of left ventricular function in hypercholesterolemia and its reversibility after short term treatment with rosuvastatin A preliminary echocardiographic study.

Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings.

Echocardiographic features of primary pulmonary hypertension.

Echocardiographic parameters and all-cause mortality: the Rotterdam Study.

Effect of angiotensin-converting enzyme inhibition on sympathetic tone in patients with mild to moderate heart failure.

Effect of baseline cognitive function and antihypertensive treatment on cognitive and cardiovascular outcomes: Study on COgnition and Prognosis in the Elderly (SCOPE).

Effect of physical exercise in hypobaric conditions on atrial natriuretic peptide secretion.

Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomized, double-blind, placebo-controlled trial.

Effect of statins on beta-amyloid metabolism in humans: potential importance for the development of senile plaques in Alzheimer's disease.

Effects of spironolactone on endothelial function, vascular angiotensin converting enzyme activity, and other53 prognostic markers in patients with mild heart failure already taking optimal treatment.

Effects of valsartan on circulating brain natriuretic peptide and norepinephrine in symptomatic chronic heart failure: the Valsartan Heart Failure Trial (Val-HeFT).

Efficacy of rosiglitazone in a genetically defined population with mild-to-moderate Alzheimer's disease.

Elevation of plasma brain natriuretic peptide is a hallmark of diastolic heart failure independent of ventricular hypertrophy.

Endothelial dysfunction and damage in congestive heart failure: relation of flow-mediated dilation to circulating endothelial cells, plasma indexes of endothelial damage, and brain natriuretic peptide.

Estimation of the concentration of lowdensity lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Evaluation of brain natriuretic peptide as marker of left ventricular dysfunction and hypertrophy in the population.

Evolution of blood pressure in patients with Alzheimer's disease: a one year survey of a French Cohort (REAL.FR).

F e l d m an H H , D ood y R S , Ki v i p e l to M , S p ar k s D L , W a te r s

General information and national estimates on diabetes in the United States.

Global burden of hypertension: analysis of worldwide data.

Global prevalence of dementia: a Delphi consensus study.

H l a tk y M A , G r e en l an d P , A r n e tt D K , B a l l a n ty n e CM , C r i qu i M H , E l k i n d

High density lipoprotein and lipoprotein oxidation.

High total cholesterol levels in late life associated with a reduced risk of dementia.

Humoral and cardiac effects of TIPS in cirrhotic patients with different &quot;effective&quot; blood volume.

Hydration in cancer patients.

Hyperinsulinemia and risk of Alzheimer disease.

Hyperinsulinemia provokes synchronous increases in central inflammation and betaamyloid in normal adults.

Hypertension and cerebrovascular dysfunction.

Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus.

The interplay of cardiovascular burden with cognition and mortality

http://epublications.uef.fi/pub/urn_isbn_978-952-61-0541-3/urn_isbn_978-952-61-0541-3.pdf

The interplay of cardiovascular burden with cognition and mortality

Abstract

Similar works

Full text

Available Versions

UEF Electronic Publications